Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization
- 14 May 2010
- journal article
- assisted reproduction
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 27 (8) , 449-456
Abstract
Purpose To evaluate the role of Anti-mullerian hormone (AMH) in predicting cumulative pregnancy outcome during in-vitro fertilization (IVF) treatment. Methods Serum AMH levels on day 6 of ovarian stimulation were taken from 180 women undergoing IVF with or without intracytoplasmic sperm injection (ICSI). The main outcome measures were ongoing pregnancy in the fresh cycle, cumulative ongoing pregnancy and ovarian response. Results There was a trend of higher median AMH levels in subjects achieving ongoing pregnancy in the fresh IVF cycle. The median AMH levels were significantly higher in subjects attaining ongoing pregnancy cumulatively and in subjects showing ovarian hyper-response in the stimulated cycle. Areas under the ROC curves were 0.606 and 0.792 for the prediction of cumulative ongoing pregnancy and ovarian hyper-response respectively. Conclusions Serum AMH concentration on day 6 of stimulation was significantly higher in subjects who achieved cumulative ongoing pregnancy in IVF compared to those who did not. Serum AMH is a reasonably good predictor of ovarian hyper-response.Keywords
This publication has 37 references indexed in Scilit:
- Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory womenHuman Reproduction, 2007
- Anti-Müllerian hormone as a predictor of IVF outcomeReproductive BioMedicine Online, 2007
- Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injectionFertility and Sterility, 2007
- Anti-Müllerian Hormone Levels in the Spontaneous Menstrual Cycle Do Not Show Substantial FluctuationThe Journal of Clinical Endocrinology & Metabolism, 2006
- Serum anti-Mullerian hormone throughout the human menstrual cycleHuman Reproduction, 2006
- A systematic review of tests predicting ovarian reserve and IVF outcomeHuman Reproduction Update, 2006
- Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?Clinical Endocrinology, 2006
- Early follicular antimüllerian hormone as an indicator of ovarian reserveFertility and Sterility, 2006
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004
- Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcomeBJOG: An International Journal of Obstetrics & Gynaecology, 1998